Skip to content

Public FDA record

Z-2403-2016: OraQuick Ebola Rapid Antigen Test, Product Code 3001-2807; Intended for the qualitative detection of a

Recall record Z-2403-2016 for OraSure Technologies, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2403-2016
Company in FDA record
OraSure Technologies, Inc.
FDA classification date
Aug 17, 2016
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class I

Reason stated in the source

Failed stability testing at 8 months. This lot produced intermittent false negative results for the positive kit control with devices stored at 30C conditions.

Source facts

Action
OraSure contacted the sole customer via email and mail (letter dated July 21, 2016) to request return of all the product from the affected lot.
Initiated
2016-07-20
Root cause
Process control
Terminated
2017-05-10
Distribution
Distributed to one customer only in US state of Georgia.
Recall number
Z-2403-2016
Recall status
Terminated
CDRH record ID
148583
FDA classified
2016-08-17
Recall event number
74843

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗